This page is kept for reference and is not offered to search engines.
In other countries
The same active substances on other registers, the same brand first.
- Tri-Cira 21Canada · 0.035 MG + 0.035 MG + 0.035 MG + 0.215 MG + 0.25 MG + 0.18 MG · Tablet · Apotex INCSame form
- Tri-Cira 28Canada · 0.035 MG + 0.035 MG + 0.035 MG + 0.215 MG + 0.18 MG + 0.25 MG · Tablet · Apotex INCSame form
- Tri-Cira Lo 21Canada · 0.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.25 MG + 0.18 MG · Tablet · Apotex INCSame form
- BriladonaItaly · Compressa · Exeltis Italia S.R.L.Same form
- BriladonaItaly · Compressa · GMM Farma S.R.L.Same form
- BriladonaItaly · Compressa · BB Farma S.R.L.Same form
- Norgestimaat/Ethinylestradiol Xiromed 0,25 mg/0,035 mg tablettenNetherlands · Tablet · Medical Valley Invest ABSame form
- Cilest TabSaudi Arabia · Janssen-CilagSame form
- EstaryllaUnited States · 0.035MG; 0.25MG · tablet · XiromedSame form
- MiliUnited States · 0.035MG; 0.25MG · tablet · Aurobindo Pharma LTDSame form
- Mono-LinyahUnited States · 0.035MG; 0.25MG · tablet · Novast Labs LTDSame form
- LouBrazil · Janssen-Cilag Farmacêutica LtdaSame substance
- Tricilest TabletsTaiwan · 錠劑 · 嬌生股份有限公司Same substance
Packs
| Pack | Code | Status |
|---|---|---|
| EDELSIN comprimidos 1X21 | 697586 | |
| EDELSIN comprimidos 3X21 | 697587 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substances
- Norgestimate, Ethinyl estradiol
- Strength
- 0,250 mg + 0,035 mg
- Dosage form
- comprimido
- Route
- vía oral
- Register
- Spain (AEMPS)
- Status
- Withdrawn
- Status in the register
- Revocado
- Authorised
- 16 Apr 2013
- Registration
- BE141215
- Marketing authorisation holder
- Janssen-Cilag
- Procedure
- National, MRP or DCP
- Supply
- Medicamento Sujeto A Prescripción Médica